HK1179274A1 - Intermediate for synthesizing caspofungin and preparation method for therefor - Google Patents
Intermediate for synthesizing caspofungin and preparation method for thereforInfo
- Publication number
- HK1179274A1 HK1179274A1 HK13106387.3A HK13106387A HK1179274A1 HK 1179274 A1 HK1179274 A1 HK 1179274A1 HK 13106387 A HK13106387 A HK 13106387A HK 1179274 A1 HK1179274 A1 HK 1179274A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- therefor
- preparation
- caspofungin
- synthesizing
- synthesizing caspofungin
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/12—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains three hetero rings
- C07D487/14—Ortho-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/12—Cyclic peptides, e.g. bacitracins; Polymyxins; Gramicidins S, C; Tyrocidins A, B or C
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
- C07K1/06—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length using protecting groups or activating agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K7/00—Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
- C07K7/50—Cyclic peptides containing at least one abnormal peptide link
- C07K7/54—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring
- C07K7/56—Cyclic peptides containing at least one abnormal peptide link with at least one abnormal peptide link in the ring the cyclisation not occurring through 2,4-diamino-butanoic acid
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201110107633 | 2011-04-28 | ||
| PCT/CN2012/072714 WO2012146099A1 (en) | 2011-04-28 | 2012-03-21 | Intermediate for synthesizing caspofungin and preparation method therefor |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1179274A1 true HK1179274A1 (en) | 2013-09-27 |
Family
ID=47071596
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK13106387.3A HK1179274A1 (en) | 2011-04-28 | 2013-05-29 | Intermediate for synthesizing caspofungin and preparation method for therefor |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US9321779B2 (en) |
| EP (1) | EP2703409B1 (en) |
| JP (1) | JP6032822B2 (en) |
| KR (1) | KR20140042805A (en) |
| CN (1) | CN103003295B (en) |
| AU (1) | AU2012248013B2 (en) |
| BR (1) | BR112013026868A2 (en) |
| CA (1) | CA2833206A1 (en) |
| HK (1) | HK1179274A1 (en) |
| MX (1) | MX2013012161A (en) |
| RU (1) | RU2592280C2 (en) |
| TW (1) | TWI597293B (en) |
| WO (1) | WO2012146099A1 (en) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US9636407B2 (en) | 2012-11-20 | 2017-05-02 | Fresenius Kabi Usa, Llc | Caspofungin acetate formulations |
| CN109721641B (en) * | 2017-10-31 | 2021-08-03 | 鲁南制药集团股份有限公司 | Synthesis method of caspofungin |
| CN111233981A (en) * | 2020-03-17 | 2020-06-05 | 湖南欧亚药业有限公司 | Preparation method of caspofungin |
| CN113801202A (en) * | 2020-06-15 | 2021-12-17 | 杭州中美华东制药有限公司 | Preparation method of caspofungin acetate impurity G |
Family Cites Families (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5378804A (en) | 1993-03-16 | 1995-01-03 | Merck & Co., Inc. | Aza cyclohexapeptide compounds |
| US5552521A (en) * | 1995-02-10 | 1996-09-03 | Merck & Co., Inc. | Process for preparing certain aza cyclohexapeptides |
| US5936062A (en) | 1997-06-12 | 1999-08-10 | Merck & Co., Inc. | Process for preparing certain aza cyclohexapeptides |
| AR035808A1 (en) * | 2001-04-12 | 2004-07-14 | Merck & Co Inc | DEHYDRATION PROCESS ABLE TO MINIMIZE THE EPIMERIZATION OF A HYDROXYL GROUP BY CERTAIN EQUINOCANDINES |
| EP1785432A1 (en) * | 2005-11-15 | 2007-05-16 | Sandoz AG | Process and intermediates for the synthesis of caspofungin. |
| TW201024322A (en) | 2008-12-31 | 2010-07-01 | Chunghwa Chemical Synthesis & Biotech Co Ltd | Preparation method for nitrogen containing heterocyclic hexapeptide with high conversion rate |
| US9006391B2 (en) * | 2009-05-07 | 2015-04-14 | Dsm Sinochem Pharmaceuticals Netherlands B.V. | Method for the preparation of cyclopeptides |
| WO2011014990A1 (en) * | 2009-08-06 | 2011-02-10 | 上海天伟生物制药有限公司 | Azacyclohexapeptide or its pharmaceutical acceptable salt, preparing method and use thereof |
| CN101648994B (en) * | 2009-08-06 | 2012-09-05 | 上海天伟生物制药有限公司 | Azepine argireline or pharmaceutically acceptable salt thereof and preparation method and application thereof |
| CN101792486A (en) | 2010-04-12 | 2010-08-04 | 浙江海正药业股份有限公司 | Method for combining caspofungin acetate |
| KR101331984B1 (en) | 2010-12-09 | 2013-11-25 | 종근당바이오 주식회사 | Method of preparing a caspofungin and new intermediates thereof |
| EP2661441A4 (en) * | 2011-01-03 | 2015-04-08 | Biocon Ltd | Process for preparation of caspofungin acetate and intermediates |
-
2012
- 2012-03-21 CN CN201280002022.0A patent/CN103003295B/en active Active
- 2012-03-21 WO PCT/CN2012/072714 patent/WO2012146099A1/en active Application Filing
- 2012-03-21 JP JP2014506733A patent/JP6032822B2/en not_active Expired - Fee Related
- 2012-03-21 KR KR1020137030264A patent/KR20140042805A/en not_active Application Discontinuation
- 2012-03-21 BR BR112013026868A patent/BR112013026868A2/en not_active IP Right Cessation
- 2012-03-21 TW TW101109612A patent/TWI597293B/en not_active IP Right Cessation
- 2012-03-21 US US14/113,512 patent/US9321779B2/en not_active Expired - Fee Related
- 2012-03-21 AU AU2012248013A patent/AU2012248013B2/en not_active Ceased
- 2012-03-21 MX MX2013012161A patent/MX2013012161A/en active IP Right Grant
- 2012-03-21 EP EP12776056.9A patent/EP2703409B1/en not_active Not-in-force
- 2012-03-21 CA CA2833206A patent/CA2833206A1/en not_active Abandoned
- 2012-03-21 RU RU2013150969/04A patent/RU2592280C2/en not_active IP Right Cessation
-
2013
- 2013-05-29 HK HK13106387.3A patent/HK1179274A1/en not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2014513087A (en) | 2014-05-29 |
| JP6032822B2 (en) | 2016-11-30 |
| US9321779B2 (en) | 2016-04-26 |
| MX2013012161A (en) | 2014-07-30 |
| TW201309732A (en) | 2013-03-01 |
| EP2703409B1 (en) | 2017-01-18 |
| WO2012146099A1 (en) | 2012-11-01 |
| RU2592280C2 (en) | 2016-07-20 |
| BR112013026868A2 (en) | 2016-09-06 |
| CA2833206A1 (en) | 2012-11-01 |
| TWI597293B (en) | 2017-09-01 |
| RU2013150969A (en) | 2015-11-10 |
| EP2703409A1 (en) | 2014-03-05 |
| US20140058082A1 (en) | 2014-02-27 |
| EP2703409A4 (en) | 2014-10-29 |
| AU2012248013B2 (en) | 2016-07-14 |
| AU2012248013A1 (en) | 2013-11-14 |
| CN103003295A (en) | 2013-03-27 |
| CN103003295B (en) | 2014-09-17 |
| KR20140042805A (en) | 2014-04-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HRP20181320T8 (en) | Human anti-tau antibodies | |
| GB2528399B (en) | Catalyst and method for its preparation | |
| ZA201206832B (en) | Novel peptides and method for their preparation and use | |
| EP2744331A4 (en) | Methods and intermediates for preparing macrolactams | |
| PL2774933T3 (en) | Ulipristal acetate preparation method and intermediate thereof | |
| ZA201305972B (en) | Method for the preparation of biphephos | |
| IL227593A (en) | Method for preparing noribogaine from voacangine and purification thereof | |
| EP2774982A4 (en) | Method for secreting and producing proteins | |
| EP2479304A4 (en) | Preparation method for aluminum-zirconium-titanium-carbon intermediate alloy | |
| EP2558587A4 (en) | Method for displaying antibodies | |
| EP2735570A4 (en) | Antibiotic peptide and preparation method therefor and application thereof | |
| ZA201306650B (en) | Sildenafil-free base-containing film preparation and method for producing same | |
| EP2725033A4 (en) | Method for producing protein preparation | |
| EP2619169A4 (en) | Method for preparing bromourea | |
| SG11201402998PA (en) | Hydroxy-aminopolymers and method for producing same | |
| SG11201400909WA (en) | Composition and method for producing same | |
| EP2676975A4 (en) | Solventless composition and method for preparing same | |
| EP2594552A4 (en) | Method for preparing ramalin | |
| EP2698159A4 (en) | Pitavastatin-containing preparation and method for producing same | |
| EP2691767A4 (en) | Method and means for sample preparation | |
| ZA201308858B (en) | New means and methods for producing propanediol | |
| HK1179274A1 (en) | Intermediate for synthesizing caspofungin and preparation method for therefor | |
| EP2599787A4 (en) | Method for producing peptide | |
| EP2657245A4 (en) | Fructosylated mangiferin and preparation method therefor and use thereof | |
| SG11201401540WA (en) | Method for synthesizing proteins |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20220317 |